Medicine & Life Sciences
Squamous Cell Neoplasms
100%
Head and Neck Neoplasms
80%
Head
58%
Patents
38%
Clinical Trials
31%
ErbB Receptors
30%
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
25%
Erlotinib Hydrochloride
20%
Hypoxia-Inducible Factor 1
20%
Cetuximab
20%
Gefitinib
20%
Vascular Endothelial Growth Factor Receptor
19%
Biological Therapy
18%
Survival
17%
Somatomedins
17%
Epithelial-Mesenchymal Transition
16%
Transferases
16%
Phosphatidylinositol 3-Kinases
15%
Genetic Therapy
14%
Protein-Tyrosine Kinases
14%
Immunotherapy
14%
Patient Selection
14%
Therapeutics
13%
Radiation
12%
Monoclonal Antibodies
11%
Biomarkers
10%
Neoplasms
5%
Chemical Compounds
Vandetanib
76%
Transferase Inhibitor
66%
Gefitinib
63%
Erlotinib
63%
Tyrosine Kinase Inhibitor
56%
Antiangiogenic
55%
Antagonist
37%
Biological Marker
36%
Antineoplastic Agent
35%
Resistance
25%